Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of bevacizumab effect on diabetic macular edema
IRCT20190518043622N1Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab in diabetic macular edema (DME), sponsored by Shiraz University of Medical Sciences. Started Jun 2018; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT20190518043622N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190518043622N1.